Search
Tirzepatide
go.drugbank.com/drugs/DB15171ApprovedInvestigational[L48766] On September 15, 2022, tirzepatide was also approved by the European Commission.[L44386]. On November 02, 2023, tirzepatide was also approved by the Health Canada [L52800] … [A246260] Its protein sequence was based on the sequence of endogenous GIP, and its pharmacological action on GLP-1 receptors is comparable to endogenous GIP; however, the long half-life of tirzepatide
Categories: Drugs Used in Diabetes, Receptors, G-Protein-CoupledProducts: Mounjaro 2.5 mg solution for injection in pre-filled pen, Mounjaro 5 mg solution for injection in pre-filled penZinc gluconate
go.drugbank.com/drugs/DB11248ApprovedInvestigationalVet approvedStudies show that zinc may be better absorbed in humans in the gluconate form [A32412], [L2105], however, results from other studies may vary. … More information about Zinc (in its natural form) is available at [DB01593].
Mixtures: FERROZINC - G SURUP, 100 ML, Dr. AVi VITAMIN C 1000 mg with Zinc, Real Ginger, Honey, Lemon and LemongrassProducts: NATURE'S BOUNTY CHELATED ZINC 50 MG GLUCONATE TABLET, 100 ADET, ZINC 50 MG.Oseltamivir
go.drugbank.com/drugs/DB00198ApprovedInvestigational[A179962, A179965, A179968] Due to the risk of adverse effects such as nausea, vomiting, psychiatric effects and renal adverse events in adults and vomiting in children, the harms are generally considered … Notably, in 2017, the World Health Organization downgraded oseltamivir from its essential medicines list from a "core" drug to a "complementary" drug, due to limited cost-effectiveness.
Products: FLUHALT FOR ORAL SUSPENSION 60 mg/ 5 ml, TAMIFLU ROCHE 12 MG/ML ORAL SÜSPANSIYON TOZU, 30 GInterferon alfa-2b
go.drugbank.com/drugs/DB00105ApprovedInvestigationalInterferon alpha 2b (human leukocyte clone hif-sn 206 protein moiety reduced). A type I interferon consisting of 165 amino acid residues with arginine in position 23. … It is used extensively as an antiviral or antineoplastic agent.
Mixtures: Rebetron Ready To Use Solution (albumin(human)free) (6000000 Iu/ml and 200mg Capsules), Rebetron Solution (albumin (human) Free) (18 Miu Multi-dose Pen / 200mg Capsules)Products: VIRAFERON INYECTABLE 3 MILLONES IU, BETAFERON 0.3 MG LIYOFILIZE TOZ ICEREN FLAKON + KULLANIMA HAZIR ENJEKTORDE COZUCU, 12 ADETBromelains
go.drugbank.com/drugs/DB13281ApprovedInvestigationalBromelain is a protease enzyme derived from the stems of pineapples that is composed of a mixture of different thiol endopeptidases and other components like phosphatase, glucosidase, peroxidase, cellulase, escharase, and several proteas...
Products: Bromelain Pineapple Enzyme 50 Mg Nu Life, Bromelain 250Eprosartan
go.drugbank.com/drugs/DB00876ApprovedInvestigationalEprosartan is an angiotensin II receptor antagonist used to treat hypertension. It performs 2 actions on the renin angiotensin system.
Synonyms: (E)-3-[2-n-butyl-1-{(4-carboxyphenyl)methyl}-1H-imidazol-5-yl]-2-(2-thienyl)methyl-2-propenoic acid, (E)-2-butyl-1-(p-carboxybenzyl)-α-2-thenylimidazole-5-acrylic acidMixtures: Teveten Plus 600 mg/12,5 mg Filmtabletten, TEVETEN PLUS 600 MG/12.5 MG FİLM KAPLI TABLET, 28 ADETVaricella zoster vaccine (live/attenuated)
go.drugbank.com/drugs/DB10318ApprovedInvestigationalFirst approved in May 2006 by the Food and Drug Administration, Zostavax was the first vaccine available for the prevention of shingles. … Since October 2017, however, it has been replaced as first line therapy by Shingrix ([DB13924]), a more effective and longer lasting vaccine[L1038].
Mixtures: Priorix - Tetra Pulver in einer Durchstechflasche und Lösungsmittel in einer Fertigspritze zur Herstellung einer Injektionslösung, PROQUAD 0.5 ML ENJEKSIYONLUK SÜSPANSIYON HAZIRLAMAK IÇIN LIYOFILIZE TOZ IÇEREN FLAKON VE ÇÖZÜCÜ IÇEREN ENJEKTÖR , 1 ADETProducts: VARIVAX® VACUNA DE VIRUS ATENUADOS VIVOS DE VARICELA ., VARIVAX Pulver und Lösungsmittel zur Herstellung einer Injektionssuspension in einer FertigspritzeOmalizumab
go.drugbank.com/drugs/DB00043ApprovedInvestigational[A39518] Omalizumab was first approved in the US in 2003 [A263507] and in Europe in 2005. … Omalizumab is a recombinant DNA-derived humanized monoclonal antibody directed against human immunoglobulin E (IgE).
Products: XOLAIR ® 150 MG, Xolair 150mg/ml Solution for Injection in Pre-filled SyringeEsketamine
go.drugbank.com/drugs/DB11823ApprovedInvestigationalThe FDA approved ketamine (Ketalar) in 1970. … [L5593] Esketamine may prove to be a promising treatment for patients diagnosed with major depressive disorder who have not experienced an improvement in symptoms despite treatment with various medications
Categories: Non-Competitive N-Methyl D-Aspartate (NMDA) Receptor AntagonistsProducts: Eskelan 25 mg/ml-Injektions-/Infusionslösung in Ampullen, Eskelan 25 mg/ml-Injektionslösung in DurchstechflaschenDenosumab
go.drugbank.com/drugs/DB06643ApprovedInvestigational[A263066] Denosumab was approved by the FDA approved on June 2010 for the treatment of osteoporosis in postmenopausal women. … ; Both biosimilars also received marketing authorization in the EU in May 2024.
Products: XGEVA® 120 MG/1.7 ML, Prolia Solution for Injection 60 mg/ml (Prefilled Syringe)